Diagnosis and management of postural orthostatic tachycardia syndrome

Author/s: 
Raj, S. R., Fedorowski, A., Sheldon, R. S.
Date Added: 
March 22, 2022
Journal/Publication: 
Canadian Medical Association Journal
Publisher: 
Canadian Medical Association
Publication Date: 
March 14, 2022
Issue: 
10
Volume: 
194
Pages: 
E378-E385
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
https://doi.org/10.1503/cmaj.211373
PMID (1): 
35288409

RPR Commentary

A concise review of the diagnosis and management of Postural Orthostatic Tachycardia Syndrome (POTS). James W. Mold, MD, MPH

Abstract

Postural orthostatic tachycardia syndrome (POTS) is a chronic multisystem disorder; the cardinal feature is orthostatic tachycardia.

Patients with POTS have symptoms of orthostatic intolerance that improve with recumbence.

Girls and women are more commonly affected with POTS, beginning in puberty and through early adulthood.

Postural orthostatic tachycardia syndrome can lead to marked functional disability, often limiting work or schooling.

Treatments for POTS can improve symptoms and function, and can be initiated in primary care.

The main characteristic of postural orthostatic tachycardia syndrome (POTS) is tachycardia when standing, without a drop in blood pressure. Patients describe lightheadedness and palpitations when upright, particularly when standing, which sometimes leads to syncope. Patients may experience impaired quality of life and functional disability, which can be economically devastating.1–3 The syndrome is more common in girls and young women and has been associated with other disorders, like migraine and Ehlers–Danlos syndrome.4 We discuss the diagnosis of POTS, conditions to consider in the differential diagnosis, associated disorders and the pharmacologic and nonpharmacologic management of patients with POTS, based on original research, narrative reviews and consensus statements

Text Availability

Free full text